Compare Adaptive Biotechnologies Corp (ADPT) vs Carparts.Com Inc (PRTS) Price & Performance

ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.

Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.

CarParts.com (PRTS) trades at $6.14, down 0.65% on the day, following a recent 10:1 reverse stock split that helped it regain Nasdaq compliance. The stock shows a bearish technical signal with negative cash flow and net losses, though it has beaten earnings estimates for three consecutive quarters. Recent developments include a new $25 million credit facility and the launch of a co-branded Mastercard, signaling efforts to stabilize operations and enhance customer financing options.

Despite persistent losses and negative cash flow, PRTS maintains a low P/S ratio of 0.07 and has analyst support with 60% buy ratings. The primary risk is sustained profitability challenges amid declining revenue, but cost discipline and new financial tools may provide a path to recovery if execution improves.